Stock Research: Inspire Medical Systems

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Inspire Medical Systems

NYQ:INSP US4577301090
68
  • Value
    53
  • Growth
    23
  • Safety
    Safety
    100
  • Combined
    71
  • Sentiment
    41
  • 360° View
    360° View
    68
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Inspire Medical Systems, Inc. is a medical technology company developing minimally invasive solutions for obstructive sleep apnea (OSA). It operates in the medical technology industry with its proprietary Inspire therapy. The company sells its Inspire system in the United States, Europe, Japan, Singapore, and Hong Kong. In the last fiscal year, the company had a market cap of $3775 million, profits of $680 million, revenue of $803 million, and 1246 employees.

more
Index
D.J. US Medical Equipment
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
53 9 19 7
Growth
23 81 81 97
Safety
Safety
100 100 35 4
Sentiment
41 96 37 96
360° View
360° View
68 98 32 56
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
20 49 49 60
Opinions Change
85 89 43 67
Pro Holdings
n/a 84 1 82
Market Pulse
64 89 78 69
Sentiment
41 96 37 96
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
53 9 19 7
Growth
23 81 81 97
Safety Safety
100 100 35 4
Combined
71 85 32 25
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
66 22 19 1
Price vs. Earnings (P/E)
20 5 20 10
Price vs. Book (P/B)
74 32 19 4
Dividend Yield
1 1 1 1
Value
53 9 19 7
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
43 76 82 83
Profit Growth
15 80 52 52
Capital Growth
92 53 86 73
Stock Returns
9 53 41 75
Growth
23 81 81 97
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
100 100 100 67
Refinancing
64 33 15 5
Liquidity
98 100 23 23
Safety Safety
100 100 35 4

Similar Stocks

Discover high‑ranked alternatives to Inspire Medical Systems and broaden your portfolio horizons.

Salesforce

NYQ:CRM
Country: USA
Industry: Application Software
Size: XX-Large
Full Stock Analysis

Micron

NSQ:MU
Country: USA
Industry: Semiconductors
Size: XX-Large
Full Stock Analysis

Walt Disney

NYQ:DIS
Country: USA
Industry: Movies & Entertainment
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NSQ:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

The value case is weak (expensive and low Growth Rank), but sentiment is strong and financing is safe. This scenario may indicate future growth not yet in current financials. This is a speculative choice for investors with a high-risk appetite who are betting on the positive sentiment and safe financing to sustain a long-term turnaround.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: